Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Koninklijke Philips N.V. operates as a health technology company in North America and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, computed tomography (CT) systems, X-ray systems, and detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; integrated interventional systems; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding and digital parental solutions; and male grooming and beauty products and solutions. It has a strategic collaboration with Ibex Medical Analytics Ltd. to jointly promote the digital pathology and AI solutions to hospitals, health networks, and pathology laboratories worldwide, as well as a strategic partnership agreement with NICO.LAB. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Koninklijke Philips N.V.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

CAMBRIDGE, MASS.--(BUSINESS WIRE)--PHILIPS, A GLOBAL LEADER IN HEALTH TECHNOLOGY, TODAY ANNOUNCED A PLAN FOR NEW INVESTMENTS OF MORE THAN USD 150 MILLION IN U.S. MANUFACTURING AND RESEARCH AND DEVELOPMENT (R&D). AS PART OF TODAY'S ANNOUNCEMENT, PHILIPS UNVEILED THE EXPANSION OF ITS REEDSVILLE, PA, MANUFACTURING FACILITY, WHICH PRODUCES AI-ENABLED ULTRASOUND SYSTEMS FOR HOSPITALS ACROSS THE U.S. THESE INVESTMENTS COME ON TOP OF PHILIPS' ANNUAL USD 900 MILLION R&D INVESTMENT IN THE U.S. A.

PHILIPS ANNOUNCES PLAN FOR MORE THAN USD 150 MILLION OF NEW INVESTMENT IN MANUFACTURING AND R&D IN THE U.S. TO EXPAND PRODUCTION OF AI-POWERED HEALTH TECHNOLOGY INNOVATIONS

CHICAGO, AUG. 12, 2025 (GLOBE NEWSWIRE) -- IDLESPACETECHNOLOGY, UNDER THE BRAND LICENSE AGREEMENT IN NORTH AMERICA, TODAY ANNOUNCED ITS PARTICIPATION IN THE ACE HARDWARE FALL CONVENTION 2025, TAKING PLACE AUGUST 1214 AT MCCORMICK PLACE IN CHICAGO.

PHILIPS HOME ACCESS TO SHOWCASE SMART LOCK AND VIDEO DOORBELL INNOVATIONS AT ACE HARDWARE FALL CONVENTION 2025

JULY 29, 2025 LONG-TERM MULTIYEAR AGREEMENTS WILL SEE PHILIPS INSTALLING ITS ADVANCED AZURION IMAGE-GUIDED THERAPY SYSTEMS NATIONWIDE ACROSS ALL PROVINCES, INCLUDING RURAL AND REMOTE AREAS INITIATIVE BRINGS MINIMALLY INVASIVE CARE TO MILLIONS OF CARDIAC, STROKE AND CANCER PATIENTS IN INDONESIA COMBINES CUTTING-EDGE TREATMENT TECHNOLOGY, SERVICES AND TRAINING TO STRENGTHEN INDONESIA'S HEALTH INFRASTRUCTURE AMSTERDAM, THE NETHERLANDS AND JAKARTA, INDONESIA  IN A MAJOR STEP TOWARD TRANSFORMING HEALTHCARE DELIVERY, ROYAL PHILIPS (NYSE: PHG, AEX: PHIA), A GLOBAL LEADER IN HEALTH TECHNOLOGY AND THE INDONESIA'S MINISTRY OF HEALTH TODAY ANNOUNCED PLANS TO DEPLOY STATE-OF-THE-ART IMAGE-GUIDED THERAPY SYSTEMS NATIONWIDE, AS PART OF THEIR SIGNED AGREEMENTS, UNDER THE STRENGTHENING INDONESIA'S HEALTHCARE REFERRAL NETWORK (SIHREN) PROJECT. THE LANDMARK AGREEMENTS, RECENTLY AWARDED TO PHILIPS AFTER AN INTERNATIONAL, COMPETITIVE BIDDING PROCESS, COMBINE CUTTING-EDGE TREATMENT TECHNOLOGY, SERVICES AND TRAINING TO STRENGTHEN INDONESIA'S HEALTH INFRASTRUCTURE.

INDONESIA'S MINISTRY OF HEALTH AND PHILIPS TO DELIVER NATIONWIDE COVERAGE OF ADVANCED IMAGE-GUIDED THERAPY SYSTEMS IN INDONESIA, EXPANDING ACCESS TO CARDIAC, STROKE AND CANCER CARE IN ALL 38 PROVINCES

JULY 29, 2025 Q2 2025 GROUP HIGHLIGHTS COMPARABLE ORDER INTAKE GROWTH 6% GROUP SALES EUR 4.3 BILLION, REFLECTING 1% INCREASE IN COMPARABLE SALES INCOME FROM OPERATIONS EUR 400 MILLION ADJUSTED EBITA MARGIN INCREASED 130 BPS TO 12.4% OF SALES FREE CASH FLOW INCREASED TO EUR 230 MILLION PHILIPS INCREASES FULL YEAR 2025 OUTLOOK FOR ADJUSTED EBITA MARGIN AND FREE CASH FLOW; REITERATES COMPARABLE SALES GROWTH OUTLOOK ROY JAKOBS, CEO OF ROYAL PHILIPS: WE ARE FOCUSED ON DRIVING PROFITABLE GROWTH AND DELIVERING BETTER CARE FOR MORE PEOPLE. WE BUILT ORDER INTAKE GROWTH MOMENTUM, SUPPORTED BY OUR RECENTLY LAUNCHED AI-POWERED INNOVATIONS.

PHILIPS BUILDS STRONG ORDER INTAKE MOMENTUM AND DRIVES MARGIN EXPANSION IN Q2

JULY 24, 2025 PHILIPS WILL NOW OFFER THE LARGEST CARDIAC CARE PORTFOLIO THROUGH EPIC'S AURA PLATFORM CAMBRIDGE, MASS.  ROYAL PHILIPS (NYSE: PHG, AEX: PHIA) A GLOBAL LEADER IN HEALTH TECHNOLOGY, TODAY ANNOUNCED A COLLABORATION WITH EPIC TO INTEGRATE PHILIPS' SUITE OF CARDIAC AMBULATORY MONITORING AND DIAGNOSTICS SERVICES WITH AURA, THE SPECIALTY DIAGNOSTICS SUITE OF THE LEADING ELECTRONIC HEALTH RECORD (EHR) COMPANY.

PHILIPS ANNOUNCES COLLABORATION WITH EPIC TO ENHANCE AMBULATORY CARDIAC MONITORING

JULY 23, 2025 SUPPORTING PROSTATE CANCER DIAGNOSIS WITH MORE PRECISE GUIDANCE FOR CLINICIANS, OFFERING BETTER PATIENT CARE AMSTERDAM, THE NETHERLANDS  ROYAL PHILIPS (NYSE: PHG, AEX: PHIA), A GLOBAL LEADER IN HEALTH TECHNOLOGY, TODAY ANNOUNCED A MAJOR ADVANCEMENT IN IMAGE-GUIDED NAVIGATION FOR PROSTATE CANCER CARE WITH THE FDA 510(K) CLEARANCE OF THE LATEST PHILIPS URONAV VERSION. THE SYSTEM INCLUDES A NEW ADVANCED ANNOTATION [1] WORKFLOW THAT SUPPORTS CLINICIANS DURING FOCAL THERAPY PROCEDURES, HELPING DELIVER MORE PRECISE, MINIMALLY INVASIVE CARE.

PHILIPS ADVANCES MINIMALLY INVASIVE THERAPY PROCEDURES IN PROSTATE CANCER CARE WITH FDA 510(K) CLEARANCE FOR IMAGE-GUIDED NAVIGATION TECHNOLOGY

COMPREHENSIVE ANALYSIS OF KONINKLIJKE PHILIPS N.V. HIGHLIGHTS KEY MILESTONES, PRODUCTS, TECHNOLOGIES, AND FINANCIAL PERFORMANCE (2023-2025). THE REPORT COVERS STRATEGIC DEVELOPMENTS, M&AS, R&D INNOVATIONS, AND SUSTAINABILITY TRENDS. INCLUDES SWOT ANALYSIS, DISTRIBUTOR DETAILS, AND END-USER INDUSTRIES SERVED. COMPREHENSIVE ANALYSIS OF KONINKLIJKE PHILIPS N.V. HIGHLIGHTS KEY MILESTONES, PRODUCTS, TECHNOLOGIES, AND FINANCIAL PERFORMANCE (2023-2025). THE REPORT COVERS STRATEGIC DEVELOPMENTS, M&AS, R&D INNOVATIONS, AND SUSTAINABILITY TRENDS. INCLUDES SWOT ANALYSIS, DISTRIBUTOR DETAILS, AND END-USER INDUSTRIES SERVED.

KONINKLIJKE PHILIPS COMPANY ANALYSIS REPORT 2023-2025 | MERGERS, ACQUISITIONS, PARTNERSHIPS, COLLABORATIONS, PRODUCT LAUNCHES, AND INNOVATION INITIATIVES

JULY 17, 2025 ANUMANA'S FDA-CLEARED LEF ALGORITHM BECOMES FIRST CERTIFIED THIRD-PARTY SOLUTION AVAILABLE THROUGH PHILIPS' ECG ECOSYSTEM CAMBRIDGE, MASS.  ROYAL PHILIPS (NYSE: PHG, AEX: PHIA), A GLOBAL LEADER IN HEALTH TECHNOLOGY, TODAY ANNOUNCED THE LAUNCH OF THE PHILIPS ECG AI MARKETPLACE, A PLATFORM THAT GIVES CARDIAC CARE TEAMS ACCESS TO MULTIPLE VENDOR OFFERINGS ALL IN ONE CENTRAL LOCATION TO HELP CLINICIANS MANAGE AND IMPLEMENT AI-POWERED DIAGNOSTIC TOOLS MORE EASILY.

PHILIPS LAUNCHES ECG AI MARKETPLACE TO ENHANCE EARLY CARDIAC DIAGNOSIS

FROM JULY 8 TO 13, AMAZON SHOPPERS CAN SCORE UP TO 50% OFF THE BRAND'S BEST-SELLING SMART LOCKS  INCLUDING THE PHILIPS 4200 SERIES BUILT-IN WI-FI FINGERPR

UNLOCK SMARTER LIVING FOR LESS: BEST-SELLING PHILIPS SMART LOCK DROPS TO $94.99 FOR PRIME DAY 2025

CAMBRIDGE, MASS. & GARY, IND.--(BUSINESS WIRE)--ROYAL PHILIPS (NYSE: PHG, AEX: PHIA), A GLOBAL LEADER IN HEALTH TECHNOLOGY, AND METHODIST HOSPITALS TODAY ANNOUNCED THE HEALTHCARE PROVIDER'S STRATEGIC INVESTMENT IN PHILIPS' ADVANCED PORTFOLIO OF IMAGE-GUIDED THERAPY (IGT) SOLUTIONS THAT INTEGRATE IMAGING SYSTEMS AND SOFTWARE, WITH SPECIALIZED DIAGNOSTIC AND THERAPEUTIC DEVICES. THE NEW INTERVENTIONAL SUITES WILL SUPPORT CRITICAL HEALTH NEEDS WITHIN THE COMMUNITY INCLUDING ACTIVE STROKE TREATMENT.

METHODIST HOSPITALS SELECTS PHILIPS TO ADVANCE NEUROVASCULAR, CARDIOLOGY AND COMPLEX INTERVENTIONAL RADIOLOGY SERVICES IN NORTHWEST INDIANA

AMSTERDAM, THE NETHERLANDS  MARKING ITS TENTH ANNIVERSARY, PHILIPS FOUNDATION TODAY RELEASED ITS 2024 ANNUAL REPORT, HIGHLIGHTING A YEAR IN WHICH THE PHILIPS FOUNDATION HELPED PROVIDE ACCESS TO QUALITYHEALTHCARE FOR 46.5 MILLION PEOPLE AROUND THE WORLD A SIGNIFICANT INCREASE FROM 28 MILLION THE YEAR BEFORE. THIS PROGRESS WAS DRIVEN BY 22 NEW INITIATIVES AND FIVE NEW EARLY-STAGE CAPITAL IMPACT INVESTMENTS THAT EXPANDED PHILIPS FOUNDATION'S REACH, CHANNELING PHILIPS' HEALTH TECHNOLOGY EXPERTISE TO HELP ADDRESS THE GROWING BURDEN OF NON-COMMUNICABLE DISEASES AND MATERNAL HEALTH CHALLENGES, PREDOMINANTLY AT THE PRIMARY CARE LEVEL IN UNDERSERVED COMMUNITIES. TODAY, HALF OF THE GLOBAL POPULATION STILL DOES NOT HAVE ACCESS TO HEALTHCARE. INNOVATION AND NEW DIGITAL TECHNOLOGIES, COMBINED WITH AN ECOSYSTEM OF PARTNERS, CAN IMPROVE HEALTH OUTCOMES AND MAKE PROGRESS TOWARDS A FUTURE WHERE QUALITY HEALTHCARE IS WITHIN REACH FOR EVERYONE, SAID MARNIX VAN GINNEKEN, CHAIR OF THE BOARD OF THE PHILIPS FOUNDATION. THE FOUNDATION'S TENTH ANNIVERSARY MARKS AN IMPORTANT MILESTONE, DEMONSTRATING OUR CONTINUED COMMITMENT TO ADDRESSING THE CRITICAL NEEDS OF THE WORLD'S MOST VULNERABLE POPULATIONS. SINCE IT WAS ESTABLISHED IN 2014, PHILIPS FOUNDATION HAS BROUGHT HEALTHCARE SOLUTIONS TO SOME OF THE MOST REMOTE AND UNDERSERVED REGIONS ACROSS THE GLOBE  FROM RURAL CLINICS IN AFRICA TO URBAN SLUMS IN LATIN AMERICA. THESE EFFORTS INCLUDED GROUNDBREAKING WORK TO COMBAT NEGLECTED DISEASES SUCH AS RHEUMATIC HEART DISEASE IN COLLABORATION WITH THE WORLD HEART FEDERATION, AND CROSS-CONTINENTAL ULTRASOUND TRAINING PROGRAMS WITH RAD-AID INTERNATIONAL, ENABLING FRONTLINE HEALTHCARE WORKERS TO DETECT AND PREVENT LIFE-THREATENING CONDITIONS FOR PEOPLE LIVING IN LOW-RESOURCE SETTINGS. PHILIPS FOUNDATION CONTINUES TO BUILD SCALABLE HEALTHCARE MODELS BY PROVIDING VENTURES EARLY-STAGE CAPITAL THROUGH PHILIPS FOUNDATION IMPACT INVESTMENTS, SUPPORTING LOCALLY DRIVEN INNOVATION AND ACCELERATING ACCESS TO HEALTHC

PHILIPS FOUNDATION 2024 ANNUAL REPORT: EXPANDING ACCESS TO QUALITY HEALTHCARE FOR 46.5 MILLION PEOPLE

JUNE 5, 2025 AMSTERDAM, THE NETHERLANDS  ROYAL PHILIPS (NYSE: PHG, AEX: PHIA), TODAY ANNOUNCED THAT THE EXCHANGE RATIO FOR THE DIVIDEND FOR THE YEAR 2024 IS 1 NEW COMMON SHARE FOR EVERY 23.6353 EXISTING COMMON SHARES. THIS RATIO WAS BASED ON THE VOLUME WEIGHTED AVERAGE PRICE ON EURONEXT AMSTERDAM OF MAY 30, JUNE 2, AND 3, 2025, OF EUR 20.0600 AND WAS CALCULATED IN A MANNER THAT THE GROSS DIVIDEND IN SHARES WILL BE APPROXIMATELY EQUAL TO EUR 0.85.

Koninklijke Philips N.V.

PHG

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Koninklijke Philips N.V.

PHG.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

PHG